undamentalytics Newsletter
Sign in

Bruker Corp cash flow statement

In fiscal 2025, Bruker Corp's operations generated $134m of cash; it spent $90.8m on capital projects, leaving free cash flow of $43.3m. It returned $22.8m in dividends and $10.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations15015688133145114229131154240213332282274350251134190
Depreciation and amortisation3036535961605354646576808989115184220230
Stock-based pay6788798911111016172831252020
Capital spending163262735034343744497397921291071159197
Free cash flow13412426609581195941111911402351901452431364394
Free cash flow after stock pay12711718538871187841001791312191731182121112374
Dividends paid———————2625252525243029302323
Share buybacks——————90160152—142123153263152010—
Shares issued263588111220911373104098—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BRKR vs CRLBRKR vs MTDBRKR vs MEDP

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Bruker Corp's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bruker Corp.